Treatment of clozapine-associated tardive dyskinesia.
Lin
Chao-Cheng
CC
Bai
Ya-Mei
YM
Chen
Jen-Yeu
JY
Wang
Ying-Chieh
YC
Liou
Ying-Jay
YJ
D000328:Adult; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D018592:Cross-Over Studies; D003988:Dibenzothiepins / Q000627:therapeutic use*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D012720:Severity of Illness Index; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000523:psychology; D016896:Treatment Outcome
D018726:Anti-Dyskinesia Agents; D014150:Antipsychotic Agents; D003988:Dibenzothiepins; D003024:Clozapine; D006220:Haloperidol; C022172:zotepine